Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2009 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (313)	11/13/2009 5:04:07 PM
From: BulbaMan	Read Replies (3) \| Respond to of 418

11/13/09 update We have a Contest! GENE"s portfolio has now pulled up to within striking distance of RKRW's portfolio, with less than $8,000 difference between them. Regrettably, however, just as the Contest is getting exciting I'm off on a trip until 12/2 and won't be doing any updates until Friday, 12/5. Sorry. But I will be back with updates for the final innings of the Contest. Since we've traditionally set the Contest closing date a couple of weeks prior to year-end, I'm assuming this year's closing date will be Friday, 12/19. Hope that's Ok with everyone. As for this past week, it was another roller-coaster ride but the markets did manage to wind up higher. At Friday's close, the Nasdaq Composite Index was up 37.94% CYTD, or Contest Year To Date, (vs. up 34.41% CYTD a week ago), while the Nasdaq Biotech Index was up 13.17% CYTD (vs. up 12.04% CYTD a week ago)and the Contest median up 12.60% CYTD (vs. up 11.67% CYTD a week ago). As indicated above, GENE's portfolio (charged by ENMD) was the big gainer among the Contest contenders. The week's closing CYTD percentages are: RKRW up 104.63%, GENE up 96.84%, NIGEL up 78.88% and GEORGIA up 75.86%. At Friday's close, 19 of the 32 Contest portfolios were in the black and 15 of the 32 were beating the NBI. Enjoy the weekend biotechies! Below is the Top Ten list on 11/13/09: 11/13/09 Rank Name Profit/Loss 1 RKRW 104,628 2 GENE 96,838 3 NIGEL 78,880 4 GEORGIA 75,860 5 MIKE 64,335 6 BIOFISH 59,150 7 BULBA 58,284 8 SCARAM 43,955 9 PGO 41,747 10 ASHLEY 39,212 (All corrections, especially adjustments for splits, greatly appreciated.)